ACUTUS MEDICAL INC (AFIB) Stock Analyst Ratings
NASDAQ:AFIB - Nasdaq - US0051111096 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 43% to AFIB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.53. This target is 1600% above the current price.
AFIB was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about AFIB.
In the previous month the buy percentage consensus was at a similar level.
AFIB was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-08-16 | Goldman Sachs | Maintains | Neutral |
| 2022-06-24 | BTIG | Maintains | Buy |
| 2022-04-27 | BTIG | Upgrade | Neutral -> Buy |
| 2022-04-14 | Goldman Sachs | Maintains | Neutral |
| 2022-01-20 | BTIG | Downgrade | Buy -> Neutral |
| 2022-01-14 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2021-11-12 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2021-11-12 | Canaccord Genuity | Maintains | Buy |
| 2021-10-22 | Goldman Sachs | Initiate | Neutral |
| 2021-07-15 | Canaccord Genuity | Upgrade | Hold -> Buy |
| 2021-03-19 | William Blair | Downgrade | Outperform -> Market Perform |
| 2021-03-19 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2021-03-19 | Canaccord Genuity | Maintains | Hold |